Mark Crowther: Evidence-Based Guidance for Anticoagulant Prophylaxis in Children
Mark Crowther, University Professor and Chair, Department of Medicine at McMaster University, Fellow at Canadian Academy of Health Sciences, shared American Society of Hematology’s post on LinkedIn:
“Congratulations to the authors on this important work – Pediatric thrombosis has been generally overlooked despite it being a cause of significant morbidity that can last for years.
Great work by the American Society of Hematology on building its stable of Guideline initiatives.”
American Society of Hematology shared a post on LinkedIn:
“ASH and ISTH have released new clinical practice guidelines on anticoagulant prophylaxis for pediatric patients at risk of VTE, offering long-awaited, evidence-based recommendations to support care for some of the most vulnerable children.
With VTE on the rise in pediatric populations, these guidelines provide critical clarity for clinicians and highlight areas where more research is needed.
Explore the recommendations and resources in the press release.”
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience